RAO, Angela
 Distribuzione geografica
Continente #
NA - Nord America 502
EU - Europa 400
AS - Asia 96
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.001
Nazione #
US - Stati Uniti d'America 498
IE - Irlanda 118
SE - Svezia 80
CN - Cina 75
UA - Ucraina 73
DE - Germania 42
GB - Regno Unito 35
FI - Finlandia 19
CZ - Repubblica Ceca 14
SG - Singapore 14
RU - Federazione Russa 5
BE - Belgio 4
IN - India 4
CA - Canada 3
FR - Francia 3
IR - Iran 2
TN - Tunisia 2
AT - Austria 1
DK - Danimarca 1
EU - Europa 1
HR - Croazia 1
IT - Italia 1
NL - Olanda 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 1.001
Città #
Jacksonville 121
Dublin 118
Chandler 97
Nyköping 68
Ashburn 35
Beijing 30
Dearborn 28
Cambridge 18
Medford 18
Princeton 18
Des Moines 15
Boardman 14
Brno 14
Ann Arbor 12
Lancaster 10
Singapore 8
Los Angeles 7
Nanjing 6
Hebei 5
Brussels 4
Frankfurt am Main 4
Jinan 4
San Mateo 4
Shenyang 4
Zhengzhou 4
Edinburgh 3
Haikou 3
Munich 3
Ottawa 3
Taizhou 3
Wilmington 3
Ardabil 2
Bangalore 2
Leawood 2
Taiyuan 2
Tianjin 2
Tunis 2
Woodbridge 2
Augusta 1
Bucharest 1
Changsha 1
Copenhagen 1
Cormeilles-en-Parisis 1
Hangzhou 1
Hanover 1
Helsinki 1
Ivry-sur-Seine 1
Kemerovo 1
Kyiv 1
Lisbon 1
Manchester 1
Messina 1
Mumbai 1
Nanchang 1
New York 1
Ningbo 1
Norwalk 1
Novokuznetsk 1
Panama City 1
Paris 1
Pune 1
Riva 1
Saint Louis 1
Saint Petersburg 1
Shanghai 1
Stockholm 1
Vienna 1
Washington 1
Xiangfen 1
Zagreb 1
Ürümqi 1
Totale 731
Nome #
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 76
Anti-HIV agents: design and discovery of new potent RT inhibitors 70
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors 67
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 64
Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT-inhibitors. 61
Efficient 3D Database screening for novel HIV-1 IN inhibitors 60
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 59
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 59
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones 58
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 55
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin- 4-(thi)one derivatives 55
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents 55
Synthesis and structural features of new cyclofunctionalized benzimidazoles 51
Synthesis and antitumour activity of 1H,3H-thiazolo[3,4- a]benzimidazole derivatives 50
Synthesis of new potential HIV-1 integrase inhibitors 50
7-Chloro-1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazole and 1-(2,6-difluorophenyl)-6-methyl-1H,3H- thiazolo[3,4-a]benzimidazole 46
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4- a] benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors 43
Synthesis and anti-HIV activity of 1-(2,6-difluorophenyl)- 1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2- substituted benzimidazoles 39
Totale 1.018
Categoria #
all - tutte 4.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.338


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020135 0 0 0 17 0 27 22 21 2 28 18 0
2020/2021111 18 0 24 1 1 17 0 17 0 18 14 1
2021/2022120 5 35 2 3 8 0 11 3 0 1 15 37
2022/2023391 23 32 27 23 32 42 5 35 149 2 20 1
2023/202479 5 13 2 22 5 13 1 0 0 2 1 15
2024/202535 5 13 10 7 0 0 0 0 0 0 0 0
Totale 1.018